Fulcrum Therapeutics

United States

Last Updated May 8, 2025

Company Overview

Company Name

Fulcrum Therapeutics

Address

United States

About Fulcrum Therapeutics

Fulcrum Therapeutics is a United States-based company focused on modulating gene expression to treat the root cause of genetically defined diseases. The company's lead program, pociredir, is being investigated in clinical trials to treat sickle cell disease, a condition with high unmet medical need. Fulcrum Therapeutics is committed to improving the lives of patients with genetically defined diseases.

Frequently Asked Questions about Fulcrum Therapeutics

Social Profiles

Key Decision Makers

Swathi Srivatsa Senior Director
LinkedIn
Rasika Singh Clinical Trial Coordinator
LinkedIn
Allyson Pruski Associate Clinical Trial Manager
LinkedIn
Samantha Bure Clinical Trial Manager
LinkedIn